Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -34.33% vs 68.39% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -102.49% vs 2,929.23% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -49.46% vs 986.67% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 313.46% vs 8.33% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Sarepta Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -45.09% vs 65.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -34.33% vs 68.39% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -101.48% vs 180.30% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -102.49% vs 2,929.23% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -82.29% vs 193.66% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -49.46% vs 986.67% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -0.92% vs 4.33% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 313.46% vs 8.33% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






